Literature DB >> 1318684

Cytotoxicity of acridine compounds for Leishmania promastigotes in vitro.

K A Werbovetz1, E K Lehnert, T L Macdonald, R D Pearson.   

Abstract

The effect of mammalian and bacterial topoisomerase II inhibitors on Leishmania promastigotes was studied in vitro. Parasites were incubated with drugs, and cytotoxicity was assessed on the basis of the loss of flagellar motility and cell lysis after 48 h. 9-Aminoacridines, which are structurally related to the known antileishmanial compounds quinacrine and chlorpromazine, showed activity against the parasite at concentrations in the range of 10 to 20 microM. Adriamycin showed far less activity, while etoposide and several quinolones were inactive at 100-microM concentrations. These results demonstrate that a particular structural class of compounds is cytotoxic to Leishmania species. The unique structure-activity relationship discovered suggests that leishmanial topoisomerase II could be a useful target for chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318684      PMCID: PMC188468          DOI: 10.1128/AAC.36.2.495

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  RESEARCH OF ANTITUMOUR COMPOUNDS. REMARKS ABOUT THE RELATIONSHIP BETWEEN THE CHEMICAL STRUCTURE AND TUMOUR-INHIBITING ACTIVITY OF SOME ACRIDINE DERIVATIVES.

Authors:  Z LEDOCHOWSKI; A LEDOCHOWSKI; C RADZIKOWSKI
Journal:  Acta Unio Int Contra Cancrum       Date:  1964

2.  Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.

Authors:  J M Covey; K W Kohn; D Kerrigan; E J Tilchen; Y Pommier
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

3.  DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

Authors:  T C Rowe; G L Chen; Y H Hsiang; L F Liu
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  Limited activity of bacterial DNA topoisomerase II inhibitors against Leishmania donovani and Trypanosoma cruzi amastigotes in vitro.

Authors:  S L Croft; J Hogg
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

5.  Drug-promoted cleavage of kinetoplast DNA minicircles. Evidence for type II topoisomerase activity in trypanosome mitochondria.

Authors:  T A Shapiro; V A Klein; P T Englund
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

6.  Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs.

Authors:  T A Shapiro; P T Englund
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Lethal effect of phenothiazine neuroleptics on the pathogenic protozoan Leishmania donovani.

Authors:  R D Pearson; A A Manian; J L Harcus; D Hall; E L Hewlett
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

8.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.

Authors:  C P Thakur; M Kumar; A K Pandey
Journal:  Am J Trop Med Hyg       Date:  1991-10       Impact factor: 2.345

10.  Activity of oral drugs against Leishmania tropica in human macrophages in vitro.

Authors:  J D Berman; L S Lee
Journal:  Am J Trop Med Hyg       Date:  1983-09       Impact factor: 2.345

View more
  14 in total

1.  Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).

Authors:  Jason M Fritzler; Guan Zhu
Journal:  J Antimicrob Chemother       Date:  2011-12-13       Impact factor: 5.790

2.  Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major.

Authors:  Alex G Peniche; Yaneth Osorio; Adam R Renslo; Doug E Frantz; Peter C Melby; Bruno L Travi
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

3.  Bis-acridines as lead antiparasitic agents: structure-activity analysis of a discrete compound library in vitro.

Authors:  Conor R Caffrey; Dietmar Steverding; Ryan K Swenerton; Ben Kelly; Deirdre Walshe; Anjan Debnath; Yuan-Min Zhou; Patricia S Doyle; Aaron T Fafarman; Julie A Zorn; Kirkwood M Land; Jessica Beauchene; Kimberly Schreiber; Heidrun Moll; Alicia Ponte-Sucre; Tanja Schirmeister; Ahilan Saravanamuthu; Alan H Fairlamb; Fred E Cohen; James H McKerrow; Jennifer L Weisman; Barnaby C H May
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Activity and mode of action of acridine compounds against Leishmania donovani.

Authors:  C M Mesa-Valle; J Castilla-Calvente; M Sanchez-Moreno; V Moraleda-Lindez; J Barbe; A Osuna
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

5.  Effect of mitonafide analogs on topoisomerase II of Leishmania chagasi.

Authors:  K M Slunt; J M Grace; T L Macdonald; R D Pearson
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  The efficacy of enrofloxacin, alone or combined with metronidazole, in the therapy of canine leishmaniasis.

Authors:  Paolo Bianciardi; Antonio Fasanella; Valentina Foglia Manzillo; Teresa Trotta; Annalisa Pagano; Simona Sorino; Luigi Gradoni; Gaetano Oliva
Journal:  Parasitol Res       Date:  2004-07-23       Impact factor: 2.289

7.  In vitro activities of 7-substituted 9-chloro and 9-amino-2-methoxyacridines and their bis- and tetra-acridine complexes against Leishmania infantum.

Authors:  Carole Di Giorgio; Florence Delmas; Nathalie Filloux; Maxime Robin; Laetitia Seferian; Nadine Azas; Monique Gasquet; Muriel Costa; Pierre Timon-David; Jean-Pierre Galy
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Effect of structure on antibiotic action of new 9-(ethylthio)acridines.

Authors:  K Nesmĕrák; M Pospisek; B Zikánová; I Nĕmec; J Barbe; J Gabriel
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  In vitro study of anticancer acridines as potential antitrypanosomal and antimalarial agents.

Authors:  D Figgitt; W Denny; P Chavalitshewinkoon; P Wilairat; R Ralph
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

10.  9-Anilinoacridines as potential antileishmanial agents.

Authors:  J Mauël; W Denny; S Gamage; A Ransijn; S Wojcik; D Figgitt; R Ralph
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.